Correlation Engine 2.0
Clear Search sequence regions


  • ACE (4)
  • ACE2 (14)
  • ADAM17 (2)
  • antibiotics (1)
  • ARBs (1)
  • aspirin (2)
  • attacks (1)
  • azithromycin (2)
  • blood (13)
  • blood sugar (1)
  • brand (2)
  • calcium channel blockers (1)
  • cardiovascular diseases (10)
  • care patients (1)
  • cases (11)
  • cellular (1)
  • china (2)
  • chronic diseases (1)
  • ciprofloxacin (1)
  • cluster (1)
  • contain (1)
  • coronavirus (2)
  • coronavirus spike protein (1)
  • corticosteroids (4)
  • crisis (4)
  • curb (1)
  • cytokines (2)
  • d dimer (1)
  • diagnosis (1)
  • diet (3)
  • digoxin (1)
  • disease and (5)
  • diseases costs (1)
  • distress (5)
  • DM 3 (1)
  • DPP4 (4)
  • dry cough (1)
  • dyspnea (1)
  • emergency (1)
  • emesis (1)
  • epithelium (1)
  • escalates (1)
  • essential (3)
  • expert opinions (7)
  • factor (1)
  • fall (1)
  • ferritin (1)
  • flu like symptoms (1)
  • focus (3)
  • GLP 1 (2)
  • GLP1 (2)
  • glucagon (1)
  • glucagon like (1)
  • glucagon receptor (2)
  • glucocorticoids (1)
  • health policy (1)
  • health status (2)
  • heart (2)
  • heart diseases (1)
  • heart failure (2)
  • help (3)
  • homeostasis (1)
  • hormones (1)
  • human (3)
  • hyperglycemia (14)
  • hypoglycemia (3)
  • il 6 (1)
  • illnesses (1)
  • impaired (3)
  • india (12)
  • insulins (18)
  • interferons (1)
  • journal (1)
  • ketoacidosis (1)
  • lactic acidosis (1)
  • levels drugs (1)
  • liver (1)
  • lopinavir ritonavir (1)
  • lungs (7)
  • macrophage (1)
  • main (1)
  • medicines (1)
  • meta analysis (1)
  • metformin (7)
  • mortality (8)
  • nausea (1)
  • netherlands (1)
  • normal (1)
  • nph insulin (1)
  • nurses (1)
  • outbreak (1)
  • oxygen (3)
  • pathogenesis (1)
  • patients (24)
  • patients monitor (1)
  • pharmacies (1)
  • pharmacist (1)
  • phase (1)
  • physicians (4)
  • pneumonia (2)
  • poor prognostic (2)
  • problems (1)
  • prognosis (1)
  • protein binds (1)
  • protein serum (1)
  • proteins local (1)
  • rapid (6)
  • receptors (4)
  • research (2)
  • rhinorrhea (1)
  • risk benefit (2)
  • risk disease (2)
  • risk factors (6)
  • safety (1)
  • sarscov (1)
  • seasonal (1)
  • SGLT2 (2)
  • signals (1)
  • sitagliptin (1)
  • society (2)
  • sodium (2)
  • specialists (2)
  • statins (8)
  • steroid (4)
  • students (1)
  • supply (2)
  • symptoms diarrhea (1)
  • symptoms fever (1)
  • system data (1)
  • t cell (1)
  • therapies (2)
  • thrombosis (1)
  • TLR (1)
  • TNF (1)
  • TNF alpha (3)
  • transport protein (1)
  • Tumor necrosis factor (1)
  • vascular endothelium (1)
  • vegetables (1)
  • viral disease (1)
  • viral pneumonias (1)
  • virus binds (1)
  • vital (1)
  • women (1)
  • world health (2)
  • Sizes of these terms reflect their relevance to your search.

    The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment's (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints. The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion. The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic. The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic. Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.

    Citation

    Ashok Kumar Das, Sanjay Kalra, Krishnakumar B, Kamal Sharma, Mathew John, Tiny Nair, Shehla Shaikh, Deepak Khandelwal, Gagan Priya, Deep Dutta, Prathosh Gangadhar, Atul Dhingra, Mangesh Tiwaskar, Rishi Shukla, Sambit Das, Manash Pratim Baruah, Kalyan Kumar Gangopadhyay, Santosh Ramakrishnan, Vaishali Deshmukh, Arundhati Dasgupta, GVijaya Kumar, Neelam Pandey, Amya Joshi, Vineet Kumar Surana, Hitesh Punyani, Parag Shah, Aditya Rattan, Sruti Chandrasekaran, Arthur Asirwatham. Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion. Diabetes & metabolic syndrome. 2020 Nov 20;15(1):55-62

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33310177

    View Full Text